C92.1
Non-Billable

Chronic myeloid leukemia, BCR/ABL-positive

Non-Billable / Non-Specific Code

What is Chronic myeloid leukemia, BCR/ABL-positive?

ICD-10-CM C92.1 is the diagnosis code for Chronic myeloid leukemia, BCR/ABL-positive. This code falls under the section "Malignant neoplasms of lymphoid, hematopoietic and related tissue" within Chapter 2 — Neoplasms (C00-D49). It is a non-billable/non-specific ICD-10-CM code that should not be used for reimbursement. A more specific sub-code is required for billing. Medical coders and healthcare providers use this code to document and classify diagnoses in electronic health records, insurance claims, and clinical databases.

💡 Inclusions
⛔ Excludes1

Coding Guidelines for C92.1

✅ This Code Includes

  • Chronic myelogenous leukemia, Philadelphia chromosome (Ph1) positive
  • Chronic myelogenous leukemia, t(9;22) (q34;q11)
  • Chronic myelogenous leukemia with crisis of blast cells

⛔ Type 1 Excludes (Never code together)

The following conditions should never be coded at the same time as C92.1. They are mutually exclusive:

  • atypical chronic myeloid leukemia BCR/ABL-negative (C92.2-)
  • chronic myelomonocytic leukemia (C93.1-)
  • chronic myeloproliferative disease (D47.1)

ICD-10-CM Code Hierarchy

Understanding where C92.1 sits in the ICD-10-CM classification helps ensure proper coding:

Current CodeC92.1 — Chronic myeloid leukemia, BCR/ABL-positive
Sub-Codes (3)
Sub-Codes 3 entries
C92.10Chronic myeloid leukemia, BCR/ABL-positive, not having achieved remissionBillableC92.11Chronic myeloid leukemia, BCR/ABL-positive, in remissionBillableC92.12Chronic myeloid leukemia, BCR/ABL-positive, in relapseBillable
Related Codes

Frequently Asked Questions

Is C92.1 a billable ICD-10-CM code?

No, C92.1 is a non-billable/non-specific code. You should use a more specific sub-code for billing and reimbursement.

What does C92.1 mean?

C92.1 is the ICD-10-CM diagnosis code for "Chronic myeloid leukemia, BCR/ABL-positive". It is used by healthcare providers to classify and document this condition in medical records and insurance claims.

What is the parent code of C92.1?

The parent code of C92.1 is C92 ("Myeloid leukemia"). C92.1 provides a more specific classification within this category.

What section is C92.1 in?

C92.1 is located in Section C81-C96 — "Malignant neoplasms of lymphoid, hematopoietic and related tissue" within Chapter 2 of the ICD-10-CM Tabular List.

What are the sub-codes of C92.1?

C92.1 has 3 sub-code(s) that provide more specific detail: C92.10, C92.11, C92.12.

When should I use C92.1?

Use C92.1 when the patients documented diagnosis matches "Chronic myeloid leukemia, BCR/ABL-positive" and the clinical documentation supports this level of specificity. Always verify with the latest ICD-10-CM guidelines and payer requirements.

People Also Ask

What is the ICD-10 code for Chronic myeloid leukemia, BCR/ABL-positive?

The ICD-10-CM code for Chronic myeloid leukemia, BCR/ABL-positive is C92.1.

Can C92.1 be used for primary diagnosis?

No, C92.1 is non-billable. Use a more specific sub-code for primary diagnosis billing.

What chapter is C92.1 in?

C92.1 is in Chapter 2 of the ICD-10-CM Tabular List.

What conditions are excluded from C92.1?

Type 1 Excludes for C92.1 include: atypical chronic myeloid leukemia BCR/ABL-negative (C92.2-); chronic myelomonocytic leukemia (C93.1-); chronic myeloproliferative disease (D47.1).

Is C92.1 valid for 2026?

Yes, C92.1 is a valid ICD-10-CM code for the 2026 fiscal year, subject to official CMS updates.

See Also

← PreviousC92.02Acute myeloblastic leukemia, in relapseNext →C92.10Chronic myeloid leukemia, BCR/ABL-positive, not having achieved remission
Code Details
C92.1
Chronic myeloid leukemia, BCR/ABL-positive
Non-Billable / Non-Specific Code
2 — Neoplasms (C00-D49)
C81-C96 — Malignant neoplasms of lymphoid, hematopoietic and related tissue
2026 ICD-10-CM